Studies have demonstrated that the elevated expression of GPX4, a core ferroptosis regulator, is associated with high-grade thyroid cancer [85], and another key regulator, SLC7A11, is linked to poor prognosis [86]. The gene discussed is SLC7A11; the disease is thyroid gland carcinoma.